Related Experiment Videos
Inner hair cell Cre-expressing transgenic mouse
Mingyuan Li1, Yong Tian, Bernd Fritzsch
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Summary
Researchers developed a new transgenic mouse model for precise gene targeting in the inner ear's cochlear hair cells. This tool enables conditional gene manipulation in mature inner hair cells, crucial for understanding hearing.
Area of Science:
- Neuroscience
- Genetics
- Otolaryngology
Background:
- Cochlear hair cells are vital mechanosensory cells for hearing in mammals.
- Targeted genetic manipulation in hair cells requires specific Cre recombinase activity.
- Existing models may lack specificity for inner hair cells.
Purpose of the Study:
- To report a novel transgenic mouse line with Cre recombinase activity specifically in cochlear hair cells.
- To characterize the expression pattern and timing of Cre activity in this new mouse line.
- To establish a tool for conditional gene targeting in inner ear hair cells.
Main Methods:
- Generation of a transgenic mouse line expressing Cre recombinase.
- Crossing the Cre line with the ROSA26R reporter line.
- Visualization of Cre activity using X-gal staining and beta-galactosidase immunostaining.
- Analysis of Cre expression in various tissues and developmental stages.
Main Results:
- Cre activity was detected specifically in inner hair cells of the cochlea, not supporting cells.
- Expression initiated at postnatal day 14 and persisted into adulthood.
- Limited Cre activity was observed in some outer hair cells, vestibular hair cells, and spiral ganglia.
- Expression was found in brain, testis, and retina, but not in kidney, heart, liver, or intestine.
Conclusions:
- This transgenic mouse line provides a valuable tool for conditional gene targeting in mature cochlear inner hair cells.
- The specificity of Cre expression facilitates research into inner ear function and hearing disorders.
- The characterized expression pattern aids in designing targeted genetic experiments.